Aperio, the innovative leader in ePathology Solutions, proudly announces the successful raising of $9 million in funding aimed at further enhancing the digital transformation of pathology practices worldwide. With over a decade of expertise in digitizing glass slides for secure sharing, Aperio has established its cutting-edge technology as a game-changer and vital resource for hospitals, reference labs, and pharmaceutical institutions. This latest infusion of capital will bolster the development of Aperio's unique products, including the NETWORK for real-time collaboration and the PRECISION analytical tools, enabling pathologists to evaluate and share crucial data more efficiently than ever before. By integrating advanced technology into existing systems, Aperio ensures optimal transparency, consistency, and efficiency, ultimately improving patient care and supporting the growing demands of personalized medicine and research. Based in Vista, California, Aperio is committed to pioneering solutions that empower healthcare professionals, and this funding will propel their mission forward with increased capability to innovate and refine their offerings. As the medical field rapidly evolves, this partnership positions Aperio to remain at the forefront of digital pathology, continuing to provide cutting-edge solutions that enhance the quality and accessibility of diagnostic services. For more information on Aperio's groundbreaking ePathology Solutions or to stay updated on recent developments, visit www.aperio.com. This exciting funding milestone is just the beginning as Aperio continues to revolutionize the practice of pathology globally.










.png&w=3840&q=75)


